Norwegian researchers may be closing in on a mechanism that can inhibit an aggressive type of breast cancer.
Those afflicted with psoriasis, rheumatoid arthritis and kidney inflammation are all victims of their own immune system; their bodies are attacking healthy cells. Medicines targeted at one troublesome enzyme could make life easier for people suffering from these conditions Read more in English: The Research Council of Norway Psoriasis, leddgikt og nyrebetennelse er alle følger […]
The Norwegian company Avexxin has designed a molecule that may improve the lives of people afflicted with psoriasis – meaning one to three per cent of the global population. The company’s molecule is the active ingredient in a psoriasis cream soon ready for testing on patients. Read more: The Research Council of Norway
Mange kroniske sykdommer oppstår fordi immunforsvaret går til angrep på en innbilt fiende. Et nytt molekyl hindrer det i å løpe fullstendig løpsk.
1–3 prosent av verdens befolkning er angrepet av sykdommen psoriasis. \
One to three per cent of the world’s population suffers from psoriasis.